Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist available in the US under two brand names: Mounjaro (for type 2 diabetes in adults) and Zepbound (for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity)
The FDA has approved semaglutide under two brand names: Ozempic (a once-weekly injection) and Rybelsus (a once-daily oral tablet)
When used alongside these dietary foundations, L Carnitine L Tartrate becomes a toolnot a crutchfor better energy, improved fat metabolism, and peak performance
Olive oil is an amazingly good fat, as long as you dont heat it
Bottom Line GLP-1 agonists have a place in medicine as treatment for Type 2 diabetes and obesity, offering benefits in blood sugar control and weight loss
He added: Preliminary data show that tri-agonists of GIP, GLP-1 and glucagon may have greater effects than mono- and dual-agonists in reducing liver fat. Arun J
&srotate=0)
